Sporotrichoid Cutaneous Infection by Mycobacterium Haemophilum in an AIDS Patient

Nodular skin reactions in eyebrow permanent makeup: two case reports and an infection by Mycobacterium haemophilum

“…Cutaneous signs of M. haemophilum infection can vary from erythematous nodules and plaques, cysts, focal panniculitis, annular lesions, ulcers, and cellulitis 12,13 . A sporotrichoid cutaneous distribution of M. haemophilum like in our patient has been described in a 37‐year‐old AIDS patient before 14 . Contaminated ink seems to be a major source of infection (Table 3).…”

“…15,16 Most authors recommend a triple combination for successful treatment (in immunocompromised patients for at least 12 months). [12][13][14] We used ciprofloxacin 500 mg twice a day, clarithromycin 500 mg twice a day, and rifampicin 300 mg twice a day. Because duration of treatment of M. haemophilum is best guided by the patient underlying condition and clinical response, treatment has to be individualized.…”

“…Most authors recommend a triple combination for successful treatment (in immunocompromised patients for at least 12 months) 12–14 . We used ciprofloxacin 500 mg twice a day, clarithromycin 500 mg twice a day, and rifampicin 300 mg twice a day.…”

Cutaneous tuberculosis overview and current treatment regimens

“…Immuno-competent patients must continue with therapy for 6e9 months, whereas immuno-compromised patients have to continue with therapy indefinitely. Surgical excision has also been reported as being beneficial [91,108,32,80,35].…”

Nodular lymphangitis: A distinctive clinical entity with finite etiologies

“…The rare cases of nodular lymphangitis due to M. kansasii have been characterized by indolent verrucous growths at the site of inoculation and subcutaneous swellings along the involved lymphatic channels without regional lymphadenopathy [ 50 ]. Nodular lymphangitis has also been described recently in association with primary cutaneous infection by Mycobacterium haemophilum after the bite of an aquarium fi sh in a patient with advanced HIV infection [ 51 ].…”